Risk of seizure associated with use of acid-suppressive drugs: An observational cohort study-Reference-Cited by-同舟云学术

Risk of seizure associated with use of acid-suppressive drugs: An observational cohort study

Published:2016-09 Issue: Volume:62 Page:72-80
ISSN:1525-5050
Container-title:Epilepsy & Behavior
language:en
Short-container-title:Epilepsy & Behavior

Author:

Sáez María E.,González-Pérez Antonio,Gaist David,Johansson Saga,Nagy Péter^ORCID,García Rodríguez Luis A.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Neurology (clinical),Neurology

Reference43 articles.

1. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease;Sigterman;Cochrane Database Syst Rev,2013

2. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease;Donnellan;Cochrane Database Syst Rev,2005

3. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review;El-Serag;Gut,2014

4. Systematic review: patterns of reflux-induced symptoms and esophageal endoscopic findings in large-scale surveys;Dent;Clin Gastroenterol Hepatol,2012

5. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality;Lau;Digestion,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antidepressant use and the risk of seizure: a meta-analysis of observational studies;European Journal of Clinical Pharmacology;2023-11-24

2. Depression Events Associated with Proton-Pump Inhibitors in Postmarketing Drug Surveillance Data;Pharmacoepidemiology;2023-08-30

3. Association between proton pump inhibitor use and neurological or psychiatric disorders: a systematic review protocol;JBI Evidence Synthesis;2023-08-09

4. Depression events associated with proton-pump inhibitors in postmarketing drug surveillance data;2023-06-05

5. Central histaminergic signalling, neural excitability and epilepsy;British Journal of Pharmacology;2021-11-09